Loss of ADAR1 in IFN-stimulated positive tumor cells, such as triple-negative breast cancer (TNBC)23, sensitizes cancer cells to cytokine-mediated cell death, primarily through interferon-stimulated gene (ISG) activation and tumor cell apoptosis24. This evidence concerns the gene ADAR and triple-negative breast carcinoma.